Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical AdvisorHantavirus Outbreak: Expert Explains How to Protect Yourself

📡 Surveillance / Emerging Signal
WHO and CDC are tracking disembarked passengers while investigating whether transmission occurred between people rather than from rodents. Hantavirus cardiopulmonary syndrome carries a 30-40% fatality rate, with no specific treatment beyond supportive care.


Clinical Considerations

  • Andes strain is the exception: most hantaviruses are rodent-to-human only; Andes has documented person-to-person transmission requiring close contact.
  • Early presentation mimics influenza (fever, myalgias) before rapid progression to pulmonary edema, respiratory failure, and cardiovascular shock.
  • No FDA-approved vaccine or antiviral exists; management is entirely supportive, often requiring ICU-level respiratory support.
  • Typical US exposures involve aerosolized rodent excreta in enclosed spaces — attics, basements, sheds, garages, vehicles, and campsites.

Practice Applications

  • Recognize flu-like illness with rapid pulmonary deterioration as a hantavirus red flag, especially with travel or rodent exposure history.
  • Ask about recent cruise travel, cleaning of rodent-infested spaces, and outdoor exposures in unexplained febrile illness.
  • Counsel patients on mask, glove, and ventilation precautions when cleaning areas with rodent activity.
  • Monitor CDC and state health department advisories for evolving guidance on the cruise cluster.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form